CPhI North America is part of the Informa Markets Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.


View, browse and sort the ever-growing list of sessions by pass type, track, and format. With this Session Scheduler, you can build your schedule in advance and access it during the show via export or with the Mobile App, once live. Sessions do fill up and seating is first come, first serve, so arrive early to sessions that you would like to attend.

Aniruddh SinghFounder & Director, Asha Pharma - Crystallizing Hope

Aniruddh "Andy" Singh is the Founder of Asha Pharma, a San Diego based company specializing in Solid Form Screening and Selection. He has over 15 years of experience in the fields of crystallization, solid form discovery and selection, particle engineering and preformulation. Andy received his Ph.D. in Chemical Engineering and Crystallization at the Illinois Institute of Technology (IIT) with Dr. Allan S. Myerson followed by a postdoc also in Chemical Engineering and Crystallization at the Massachusetts Institute of Technology (MIT) with Dr. Bernhard Trout. 

He has worked in Solid Form and Preformulation Groups at large pharmaceutical companies such as Bristol-Myers Squibb and Boehringer Ingelheim and multiple CROs. Andy has authored 7 journal articles, 15 national/international posters/presentations, 7 patent applications (4 grants) and numerous internal technical reports. His Ph.D. work on Crystal Growth on Self-Assembled Monolayers was highlighted by CrystEngComm (a Royal Society of Chemistry Journal). He is also a reviewer for the ACS journal Crystal Growth and Design and has given invited talks at Purdue University and Industrial Symposiums.